BioXcel Therapeutics (BTAI) Stock Highlights

0.99 | -3.88%

2024-08-03 05:47:58

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501, and BXCL701.

Statistics

Range Today

0.97 1.04

Volume Today 400.2K

Range 1 Year

1.03 7.99

Volume 1 Year 395.2M

Range 3 Year

1.03 36.49

Volume 3 Year 744.47M

Range 10 Year

1.03 71.5

Volume 10 Year 993.15M

Highlights

Market Capitalization 37.16M (micro)

Floating Shares 25.82M

Current Price 0.99

Price To Earnings -0.2

Price To Revenue 37.22

Earnings Per Share -5.18

Payout Ratio 0%

Performance

Latest -3.88%

1 Month -16.1%

3 Months -61.02%

6 Months -68.67%

1 Year -86.84%

3 Years -96.2%

5 Years -90.77%

10 Years -91.02%

Benchmarks

Market Capitalization

264 / 368

Gross Profits

137 / 278

Total Revenue

233 / 300

Total Rank

272 / 368

Free Cashflow

282 / 352

Performance 5 years

302 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.